(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. Guest: Paul Wahlgren, Managing Director of Skyler Brand Ventures, on luxury skin care and their patended neuropeptide technology used in a new concentrate for the face: XEP-30.
See omnystudio.com/listener for privacy information.
